Wagner Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Wagner Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $36,693 - $40,941	-134 Reduced 57.26%	100 $29,000
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $54,980 - $68,456	234 New	234 $66,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $22,142 - $26,097	-100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $20,702 - $24,131	100 New	100 $21,000
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $20,701 - $27,608	-100 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$145.72 - $169.96 $5,100 - $5,948	35 Added 53.85%	100 $17,000
Q1 2018 May 10, 2018	BUY	$151.6 - $177.13 $1,364 - $1,594	9 Added 16.07%	65 $11,000
Q4 2017 Feb 22, 2018	BUY	$137.28 - $155.55 $7,687 - $8,710	56	56 $9,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wagner Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wagner Wealth Management, LLC with notifications on news.